Kitsap Provider Resources

Health Advisory: EzriCare Artificial Tears linked to antibiotic-resistant infections

Actions Requested Background The Centers for Disease Control and Prevention (CDC) is investigating a multistate cluster of Verona Integron‐mediated Metallo‐β‐lactamase (VIM)‐ and Guiana‐Extended Spectrum‐β‐Lactamase (GES)‐ producing carbapenem‐resistant Pseudomonas aeruginosa (VIM‐GES‐CRPA) associated with multiple  different infection types, including eye infections. Recent epidemiology and laboratory evidence link these infections to use of EzriCare Artificial Tears. These over-the-counter Health Advisory: EzriCare Artificial Tears linked to antibiotic-resistant infections

Health Advisory: King County measles case traveled through SeaTac airport

Actions Requested Background Current situation Seattle King County Public Health is investigating a local case of measles in an adult who was exposed while overseas. The case was at SeaTac airport and Providence Swedish First Hill Emergency Department during their infectious period before receiving the diagnosis of measles. The case did not wear a face Health Advisory: King County measles case traveled through SeaTac airport

Kitsap Respiratory Illness Report: January 15 – January 21, 2023

Click here to access week 3 of the Kitsap Respiratory Illness Report: 01.15.2023 – 01.21.2023. Summary: Local influenza activity is currently elevated, with 10 positive influenza tests in the past week (1,669 cumulative (21.4% of total tested) since 10/2/2022). RSV activity is currently elevated, with 8 positive RSV tests in the past week (471 since Kitsap Respiratory Illness Report: January 15 – January 21, 2023

Kitsap Respiratory Illness Report: January 8 – January 14, 2023

A black male scientist looking in a microscope in a lab with a white female scientist in the background

Click here to access week 2 of the Kitsap Respiratory Illness Report: 01.08.2023 – 01.14.2023. Summary: Local influenza activity is currently elevated, with 13 positive influenza tests in the past week (1,659 cumulative (22.3% of total tested) since 10/2/2022). RSV activity is currently elevated, with 9 positive RSV tests in the past week (463 since Kitsap Respiratory Illness Report: January 8 – January 14, 2023

Update on Pfizer COVID-19 bivalent booster

The following information was shared by the Washington State Department of Health: On January 13, the CDC announced that they will be investigating a preliminary safety signal for the Pfizer Bivalent Booster.  The safety signal was detected by the CDC’s Vaccine Safety Datalink.  Other safety systems, databases, and countries are not seeing the same link, Update on Pfizer COVID-19 bivalent booster

Kitsap Respiratory Illness Report: January 1 – January 7, 2023

Click here to access week 1 of the Kitsap Respiratory Illness Report: 01.01.2023 – 01.07.2023. Summary: Local influenza activity is currently elevated, with 36 positive influenza tests in the past week (1,646 cumulative (23.4% of total tested) since 10/2/2022). RSV activity is currently elevated, with 18 positive RSV tests in the past week (454 since Kitsap Respiratory Illness Report: January 1 – January 7, 2023

Kitsap Respiratory Illness Report: December 25 – December 31, 2022

Click here to access week 52 of the Kitsap Respiratory Illness Report: 12.25.2022 – 12.31.2022. Summary: Local influenza activity is currently high, with 113 positive influenza tests in the past week (1,610 cumulative (24.5% of total tested) since 10/2/2022). RSV activity is currently elevated, with 22 positive RSV tests in the past week (436 since Kitsap Respiratory Illness Report: December 25 – December 31, 2022

Kitsap Respiratory Illness Report: December 18 – December 24, 2022

Click here to access week 51 of the Kitsap Respiratory Illness Report: 12.18.2022 – 12.24.2022. Summary: Local influenza activity is currently high, with 229 positive influenza tests in the past week (1,497 cumulative (25.1% of total tested) since 10/2/2022). RSV activity is currently elevated, with 25 positive RSV tests in the past week (412 since Kitsap Respiratory Illness Report: December 18 – December 24, 2022

Updated bivalent COVID-19 boosters authorized for children 6 months to 5 years old

Earlier this month, U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) expanded emergency use authorization (EUA) of Moderna and Pfizer-BioNTech bivalent vaccines for children 6 months and older. Updated (bivalent) COVID-19 booster vaccines are formulated to boost immunity against the original coronavirus strain and protect against the newer omicron Updated bivalent COVID-19 boosters authorized for children 6 months to 5 years old

Newly Arrived Ukrainian Citizens’ Medical and Mental Health Needs

On April 21, 2022, President Biden announced a new Uniting for Ukraine (U4U) process to help Ukrainian citizens fleeing war come to the United States temporarily. As of November 18, 2022: Newly arrived Ukrainian citizens have various medical and mental health needs. Resources